Australia's Atomo Diagnostics climbs on order for HIV self-tests

Atomo Diagnostics

07/04/2025 04:56

** Shares of Atomo Diagnostics AT1.AX rise 6.3% to A$0.017

** Stock set for its strongest session since January 31, if current trend holds

** Medical device co says Thorne Harbour Health has placed an order worth ~230,000 for co's HIV self-tests to support initial national scale up of its CONNECT program

** Says HIV self-tests to be imported into New Zealand with launch of product through Chemist Warehouse

** 659,024 shares traded in stock's busiest session since March 11

** Stock down 10.5% YTD, including current session's moves

(Reporting by Manasi Dasa in Bengaluru)

((Manasi.DasaSundeep@thomsonreuters.com;))